Correlation Between Cullinan Oncology and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Spero Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Spero Therapeutics.
Diversification Opportunities for Cullinan Oncology and Spero Therapeutics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Cullinan and Spero is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Spero Therapeutics
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 1.46 times more return on investment than Spero Therapeutics. However, Cullinan Oncology is 1.46 times more volatile than Spero Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.4 per unit of risk. If you would invest 1,254 in Cullinan Oncology LLC on September 24, 2024 and sell it today you would lose (94.00) from holding Cullinan Oncology LLC or give up 7.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Cullinan Oncology LLC vs. Spero Therapeutics
Performance |
Timeline |
Cullinan Oncology LLC |
Spero Therapeutics |
Cullinan Oncology and Spero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cullinan Oncology and Spero Therapeutics
The main advantage of trading using opposite Cullinan Oncology and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.Cullinan Oncology vs. Fate Therapeutics | Cullinan Oncology vs. Sana Biotechnology | Cullinan Oncology vs. Caribou Biosciences | Cullinan Oncology vs. Arcus Biosciences |
Spero Therapeutics vs. Fate Therapeutics | Spero Therapeutics vs. Sana Biotechnology | Spero Therapeutics vs. Caribou Biosciences | Spero Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |